PIM kinases: From survival factors to regulators of cell motility

被引:50
|
作者
Santio, Niina M. [1 ]
Koskinen, Paivi J. [1 ]
机构
[1] Univ Turku, Sect Genet & Physiol, Dept Biol, Turku, Finland
基金
芬兰科学院;
关键词
PIM kinases; Cancer; Motility; Migration; Invasion; Metastasis; HUMAN PANCREATIC-CANCER; ADENOID CYSTIC CARCINOMA; RECEPTOR TYROSINE KINASE; PROVIRAL INSERTION SITE; PROSTATE-CANCER; PROTEIN-KINASE; GENE-EXPRESSION; C-MYC; SERINE/THREONINE KINASES; PROTOONCOGENE PIM-1;
D O I
10.1016/j.biocel.2017.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PIM kinases are oncogenic serine/threonine kinases, the expression and activities of which are tightly regulated in normal tissues, but upregulated in many types of human malignancies, including both hematological and solid cancers. Since high PIM expression levels have been connected to cancer progression and poor patient survival, PIM kinases have become attractive targets for drug development. Many downstream targets have also been identified, through which PIM kinases promote cell survival, proliferation and metabolism. More recently, PIM kinases have been implicated in regulation of cell motility, which also plays an important role in tumor growth and cancer progression. This review summarizes effects of PIM kinases and their substrates especially on cancer cell migration, invasion and metastatic growth, based on data from cell-based assays, animal experiments and patients.
引用
收藏
页码:74 / 85
页数:12
相关论文
共 50 条
  • [1] Pim Kinases: Important Regulators of Cardiovascular Disease
    Nock, Sophie
    Karim, Eima
    Unsworth, Amanda J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [2] Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
    Hammerman, PS
    Fox, CJ
    Birnbaum, MJ
    Thompson, CB
    BLOOD, 2005, 105 (11) : 4477 - 4483
  • [3] The Pim kinases control rapamycin-resistant T cell survival and activation
    Fox, CJ
    Hammerman, PS
    Thompson, CB
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (02): : 259 - 266
  • [4] The survival kinases Akt and Pim as potential pharmacological targets
    Amaravadi, R
    Thompson, CB
    JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10): : 2618 - 2624
  • [5] Pim kinases and Pim inhibitors in the regulation of prostate cancer cell migration and invasion
    Eerola, Sini
    Santio, Niina
    Tuomela, Johanna
    Rainio, Eeva-Marja
    Moreau, Pascale
    Anizon, Fabrice
    Corthals, Garry
    Harkonen, Pirkko
    Koskinen, Paivi
    CANCER RESEARCH, 2015, 75
  • [6] TAM kinases as regulators of cell death
    Post, Sean M.
    Andreeff, Michael
    DiNardo, Courtney
    Khoury, Joseph D.
    Ruvolo, Peter P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (06):
  • [7] PIM Kinases Are Essential for Chronic Lymphocytic Leukemia Cell Survival (PIM2/3) and CXCR4-Mediated Microenvironmental Interactions (PIM1)
    Decker, Sarah
    Finter, Johannes
    Forde, Aaron James
    Kissel, Sandra
    Schwaller, Juerg
    Mack, Thomas Sebastian
    Kuhn, Anabel
    Gray, Nathanael
    Follo, Marie
    Jumaa, Hassan
    Burger, Meike
    Zirlik, Katja
    Pfeifer, Dietmar
    Miduturu, Chandrasekhar V.
    Eibel, Hermann
    Veelken, Hendrik
    Dierks, Christine
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1231 - 1245
  • [8] Insulin-like growth factors as regulators of cell motility - Signaling mechanisms
    Leventhal, PS
    Feldman, EL
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1997, 8 (01): : 1 - 6
  • [9] PIM kinases regulates tumor associated macrophage survival and inflammatory signaling
    Clements, Amber N.
    Warfel, Noel A.
    CANCER RESEARCH, 2023, 83 (11)
  • [10] The Pim protein kinases regulate energy metabolism and cell growth
    Beharry, Zanna
    Mahajan, Sandeep
    Zemskova, Marina
    Lin, Ying-Wei
    Tholanikunnel, Baby G.
    Xia, Zuping
    Smith, Charles D.
    Kraft, Andrew S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (02) : 528 - 533